Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
ConditionOSA
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-90
SponsorWoolcock Institute of Medical Research
About this trial
The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA).
Eligibility criteria
Qualifiers
Adults aged 20-90 years old at time of assessment.
Attending the Woolcock Institute for an overnight sleep study for investigation of sleep apnoea.
Able to give informed consent.
Fluent in English.
Disqualifiers
Unable to understand study procedure.
Unable to sign informed consent form.
Trial design
Treatments tested in this trial
- Sleeptracker-AI
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Woolcock Institute of Medical Research
Lead sponsor
Fullpower Technologies, Inc.
Collaborator
Source ClinicalTrials.gov